NMI TT Pharmaservices, a nonclinical CRO based in Reutlingen, Germany, is establishing a new branch in Berlin.
The new outstation is located on the Bayer HealthCare campus, within the CoLaborator building that is rented out by Bayer to smaller companies and startups. NMI TT Pharmaservices will be using the new and already functional laboratory space to provide life science researchers with its proprietary DigiWest multiplex protein profiling services, to accelerate lead characterization, disease mechanism and drug mode-of-action analyses as well as biomarker identification projects for industrial clients and academic partners alike. In addition, the new office will play a key role for advancing NMI TT Pharmaservices’ market positioning by expanding its business activities beyond the existing well-established customer base.
“The chances of this new endeavor are manifold,” said Dr. Christoph Sachse, site head of the NMI TT Berlin operation. “We expect that being closer to the needs of pharma R&D scientists and the lively Berlin biotech community will substantially help us in further developing and in marketing our wide range of contract research offerings, in particular our multiplex protein profiling platform, but also our capabilities in cellular assays and in generating customized cell lines.”